Researchers developed more affordable ways to make nanoparticles, according to a study conducted on March 7, 2018.
This new method will empower laboratories to easily create nanoparticles. Researchers have showed the method of standardizing production of nanoparticles to guarantee stability and reproducibility along with an increase in yield. They made use of an affordable piece of benchtop equipment for the manufacturing of nanoparticles.
Ennio Tasciotti, Director of the Center for Biomimetic Medicine said, “Nanoparticles are generally made through cryptic protocols, and it’s very often impossible to consistently or affordably reproduce them.” For decades, bioinert or inorganic substances that does not interact with the body are being used for making nanoparticles. Nanoparticles were made to be bioactive in the recent years and now, this new development creates biomimetic nanoparticles.
Tasciotti said, “In my lab, we make nanoparticles out of the cell membrane of the very same immune cells that patrol the blood stream.” When the nanoparticles are put back into the body, it is not recognized as something different by the immune cells. Although the research will be continued by them, if anyone develops solution using their protocols that can be used in clinical care, it will still be a good outcome.
In future, this research will help in developing new methods to deliver biotherapeutic drugs. Furthermore, it is expected to increase the Global Nanoparticles Market, as elaborated in the global nanoparticles market report published by Coherent Market Insights.